Top 20 stocks in focus: Infosys, Coal India, Tata Power

Check out the companies which will be in focus during trade today based on recent and latest news developments.

SBI: ChrysCapital Investment Advisors India Pvt. Ltd and Singapore’s sovereign wealth fund GIC Pte. Ltd ​are planning to acquire 5% stake in National Stock Exchange of India Ltd (NSE), according to reports.

Aviation stocks in focus: Aviation stocks are likely to be in focus. The cabinet is likely to take a call on 5/20 rule today and may modify it, as per media report.

Coal India: The company said its subsidiary South Eastern Coalfields Ltd will buy back shares worth Rs.1,200.19 crore.

Infosys: Infosys has added almost Rs. 1 lakh crore in market value in the last two years, says report.

Tata Power : The company will buy 25% of Resurgent Power for $300 million as part of a consortium to primarily buy both coal-fired and hydro power assets in India, besides looking at power transmission companies, as per media report.

PNB: Punjab National Bank declared a list of 913 willful defaulters, including Kingfisher Airlines and NAFED, with total outstanding dues of Rs.11,486 crore.

Aurobindo Pharma: FIPB has approved two FDI proposals, including that of Aurobindo Pharma, as per media report.

Fertiliser stocks: Union Minister of State for Chemical and Fertilizer Hansraj Gangaram Ahir said that it will not increase the prices of urea for the next 3 years.

​​Crompton Greaves Consumer Electricals Ltd: The company said HDFC Mutual Fund has trimmed its stake in the company by 2.01% to 7.20% by sale​ of​ shares worth ​Rs.​168 crore in the open market.

Bharti Infratel: The telecom company will buy back shares worth Rs.2,000 crore from shareholders.

Aditya Birla Nuvo: Aditya Birla Nuvo announced in reference with the Joint Venture Agreement entered into by the Company with MMI Holdings, a leading South African Insurance based financial services group, to enter into the Health Insurance and Wellness business in India, subject to the regulatory approvals.

Suven Life Sciences Ltd: The company announced that the grant of one product patent from Canada and one product patent from Hong Kong corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032 and 2030 respectively.

Dewan Housing Finance Corporation Ltd: The Company proposes to issue Secured Redeemable Non Convertible Debentures amounting to Rs. 400.00 Crore and a Greenshoe option up to Rs. 175.00 Crore on Private Placement basis, pursuant to special resolution passed by the shareholders of the Company at the 31st Annual General Meeting held on July 23, 2015, on the terms and conditions.

HDIL: The real estate company is in talks to sell 3-4 land parcels near Mumbai as it looks to bring down its net debt to about Rs.2,000 crore by the end of this fiscal.

Union Bank of India: The Bank intends to raise capital funds through issuance of Tier 2 bonds. In this regard, CRISIL Ratings has assigned 'CRISIL AAA' rating with negative outlook to the Bank's proposed Basel III compliant Tier 2 bond issue of Rs. 1000 crore.

Satin Creditcare Network Limited: The company has raised Rs. 25 crore by issuing Non-Convertible, Redeemable, Cumulative, Preference Shares (“NCRCPS”) to Karvy Capital Limited. IFMR Capital executed the private placement of the CARE BBB rated Preference shares at coupon of 12.10% p.a and redeemable after approximately 5 years.

Kwality Ltd :The board has approved raising up to Rs.60 crore by way of preferential allotment of equity shares, convertible warrants and compulsory convertible debentures from "persons/entities other than promoter group".

Tata Motors: According to the Cogencis report, the company's luxury car making arm Jaguar Land Rover has started a new manufacturing plant in Brazil.

Union Bank of India: The bank is planning to raise funds through the issuance of Basel III-compliant tier-II bonds.

Live Stock Market Updates - Sensex, Nifty languish in red

Some buying activity is seen in realty, consumer durables, utilities, capital goods, pharma, banking, metal and FMCG sectors, while IT, energy, telecom, finance and oil & gas showing weakness on BSE. The BSE Mid-cap Index is trading up 0.06% at 11,327, whereas BSE Small-cap Index is trading up 0.56% at 11,375.


The BSE Sensex opened 85.73 points, or 0.32% up at 26482.50, while NSE Nifty opened 23.80 points, or 0.29% up at 8,134.40.

At 1:29 PM, the S&P BSE Sensex is trading at 26,328 down 69 points, while NSE Nifty is trading at 8,050 down 25 points.

India's annual wholesale price inflation (WPI) moved further higher into the positive zone at 0.79% against 0.34% in April and -2.20%  in the corresponding month of the previous year.

The BSE Mid-cap Index is trading up 0.06% at 11,327, whereas BSE Small-cap Index is trading up 0.56% at 11,375.

Adani Ports, Cipla, SBI, Tata Motors, ITC and GAIL are among the gainers, whereas HDFC, HUL, TCS, Hero MotoCorp, and Bajaj-Auto are losing sheen on BSE.

Some buying activity is seen in realty, consumer durables, utilities, capital goods, pharma, banking, metal and FMCG sectors, while IT, energy, telecom, finance and oil & gas showing weakness on BSE.

The INDIA VIX is up 4.49% at 17.3275. Out of 1,810 stocks traded on the NSE, 470 declined, 1,047 advanced and 293 remained unchanged today.

A total of 56 stocks registered a fresh 52-week high in trades today, while 15 stocks touched a new 52-week low on the NSE.

The Indian rupee depreciated against US Dollar in early trade. The rupee hit fresh 1-week low against US Dollar on sustained demand for the American currency from importers and bankers. Currently, the rupee trading at 67.16/$, down 3 paise.

Asian markets are trading on a mixed note. Nikkei 225 and Hang Seng in red. Shanghai Composite marginally up. Wall Street ended lower for a third straight session as Microsoft and Apple dragged on indexes.
On the economy front, CPI inflation increased to 21-months high of 5.76% in May 2016, while recording rise for second straight month. The CPI inflation had stood at 5.47% in April 2016. Investors also remained cautious ahead of WPI Inflation data for May which is scheduled to be released later in the day.

Reliance Defence stock was up by 2% at Rs. 62. Report says that the company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

Reliance Defence stock was up by 2% at Rs. 62. Report says that the company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

Deepak Fertilisers & Petrochemicals Corp Ltd jumped 6.5% to Rs.165 from its previous closing of Rs. 154.8 on the BSE. The company stated that Ministry of Chemicals and Fertilizers has agreed to release about Rs.485 crore outstanding subsidy payment to the company.

Unitech Ltd surged 9% to Rs.5.18 after the opening bell on the BSE. The apex consumer commission has asked the company to pay over Rs.48 lakh to a Delhi resident for failing to hand over an apartment in its Greater Noida project even after a decade, as per reports.

IVRCL Ltd has announced that pursuant to provisions of Companies Act, 2013 and SEBI (Issue of Capital Disclosure Requirement) Regulations, 2009 and implementation of SDR, the Company has made an allotment of 6,46,810 equity shares at a price of Rs. 8.765/- each, to Bank of Nova Scotia.

Jindal Steel and Power Ltd (JSPL) rose 1.2% to Rs.62.80 on the BSE. News reports stated that the company is set to get debt recast under the Reserve Bank's 5/25 scheme post deal with JSW Energy.

Jivox raises $6 million in new financing

“We view this strategic investment by one of today's frontrunners in digital marketing as strong testament to the strength of Jivox's Bangalore-based R&D team -- and clear evidence of their success in developing the world's most state-of-the art platform for personalized digital advertising”, said Naren Nachiappan, Co founder & Managing Director India of Jivox.

San Mateo California based digital marketing platform leader Jivox, having its R&D centre in Bengaluru, announced it has raised $6 million in new financing, led by the world's first “Brandtech” group You & Mr Jones and its founder David Jones, the former global CEO of advertising conglomerate Havas. You & Mr Jones will also join Jivox’s board of directors, and its senior management team will play a hands-on role in guiding the company into the next phase of its growth.

“We view this strategic investment by one of today's frontrunners in digital marketing as strong testament to the strength of Jivox's Bangalore-based R&D team -- and clear evidence of their success in developing the world's most state-of-the art platform for personalized digital advertising”, said Naren Nachiappan, Co founder & Managing Director India of Jivox."The Jivox IQ platform features the very best innovations in Big Data architectures and machine-learning algorithms, and delivers industry-leading analytics and optimization capabilities. Backed by significant new capital and strategic guidance from our expanded board, we expect to double the strength of our development team in the short term, underpinning our ability to drive even greater innovations in the future.”

“David Jones is at the vanguard of a completely new paradigm in marketing–bringing both brand expertise and a carefully curated ecosystem of the most advanced marketing technologies,” said Diaz Nesamoney, founder and CEO of Jivox. “As the only platform for personalized digital marketing within the You & Mr Jones portfolio, we’re pleased by the endorsement this confers on Jivox’s technology and our team.

“As brand marketers continue seeking ways to improve the performance of their marketing, the demand for data-driven, highly personalized marketing campaigns has skyrocketed–driving significant interest in platforms that can bring scale and automation to an otherwise complex, manual and error-prone process.”

Founded in 2007, Jivox enables some of the world's most successful brands and media companies to deliver sophisticated, highly personalized digital marketing and advertising campaigns. This new data-driven approach to digital marketing is completely transforming the way companies communicate with people.

David Jones, founder and CEO of You & Mr Jones said: “We’re extremely interested in the whole area of machine-generated creativity. We don’t believe people hate brands or branded content – they just don’t want to hear from brands they are not interested in with irrelevant messaging, hence why ad blockers are becoming so prevalent. Jivox solves this issue for brands by combining data and technology to deliver tens of thousands of different versions of highly personalized, relevant ads that are based upon what people are actually interested in.

“We think the programmatic creative space has a huge future. Jivox is a very exciting company, both in terms of what its technology offers and its proven ability to deliver for brands. Diaz’s track record speaks for itself and the Jivox platform is a great addition to our Brandtech ecosystem.”

Jivox’s impressive growth lies at the heart of a key need identified in a recent report from Accenture– The Future of Digital Advertising:“Companies not wired to be thinking about personalization will really struggle going forward. Re-targeting is not the answer; consumers move on too quickly. They want the right message, at the right time, on the right device, right now.”

Jivox brought to market the first and only platform built from the ground up to manage the complexities of personalized digital marketing. Utilizing a robust content management system, technology for dynamically assembling creative in real time and advanced machine- learning algorithms to analyze and optimize campaigns, Jivox has been credited with reinventing the market for personalized dynamic creative.

The move to programmatic media buying has significantly reduced performance and engagement by users leading them to resort to ad blocking and other means to avoid being interrupted by thousands of irrelevant ads each day. Personalized marketing technology ensures the right creative experience is delivered to the right person at the right time.

In addition to You & Mr Jones, existing investors Fortisure Ventures and Jivox CEO Diaz Nesamoney participated in the current financing round. Jivox will invest its new capital in growing sales and marketing globally as well as continuing to invest in its market-leading platform.

SKS Microfinance renamed Bharat Financial Inclusion

SKS Microfinance Ltd has announced that pursuant to the approval of the Government of India - Ministry of Corporate Affairs, Registrar of Companies, Maharashtra, Mumbai ("GOI"), the name of the Company has been changed from 'SKS Microfinance Limited' to 'Bharat Financial Inclusion Limited' w.e.f. June 13, 2016.

SKS Microfinance has announced that pursuant to the approval of the Government of India - Ministry of Corporate Affairs, Registrar of Companies, Maharashtra, the name of the company has been changed from 'SKS Microfinance Limited' to 'Bharat Financial Inclusion Limited' w.e.f. June 13, 2016.

Stock commentary:

SKS Microfinance Ltd is currently trading at Rs. 670.2, up by Rs. 1.75 or 0.2% from its previous closing of Rs. 668.4 on the BSE.

The scrip opened at Rs. 666 and has touched a high and low of Rs. 674.4 and Rs. 666 respectively. The current market cap of the company is Rs. 8514.6 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 695.6 on 09-Jun-2016 and a 52 week low of Rs. 369.4 on 18-Sep-2015. Last one week high and low of the scrip stood at Rs. 695.6 and Rs. 664.5 respectively.

The promoters holding in the company stood at 2.6% while Institutions and Non-Institutions held 77% and 20.2% respectively.

The stock is currently trading above its 50 DMA.

Ajanta Pharma launches Memantine Hydrochloride tablets in US

The company has launched it in 2 strengths 5mg & 10 mg tablets to address different levels of treatment.

Ajanta Pharma announced the launch of Memantine Hydrochloride Tablets in the US market. The company has launched it in 2 strengths 5mg & 10 mg tablets to address different levels of treatment.

Ajanta Pharma Ltd is currently trading at Rs. 1588, up by Rs. 26.7 or 1.7% from its previous closing of Rs. 1561.2 on the BSE.

The scrip opened at Rs. 1568.2 and has touched a high and low of Rs. 1593 and Rs. 1560 respectively. The current market cap of the company is Rs. 13739.7 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1720 on 12-Aug-2015 and a 52 week low of Rs. 1103 on 18-Jan-2016. Last one week high and low of the scrip stood at Rs. 1589.7 and Rs. 1531.2 respectively.

The promoters holding in the company stood at 73.78 % while Institutions and Non-Institutions held 11.67 % and 14.55 % respectively.

The stock is currently trading above its 50 DMA.

Block deal on Reliance Infra; stock up 1.5%

Around 26.6 lakh shares were traded in a single block at Rs. 541.50 on the BSE.

Reliance Infrastructure rose 1.5% to Rs. 544 on Tuesday. Around 26.6 lakh shares were traded in a single block at Rs. 541.50 on the BSE.

The scrip opened at Rs. 538 and has touched a high and low of Rs. 548.6 and Rs. 538 respectively. The current market cap of the company is Rs. 14100.2 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 622 on 05-Jan-2016 and a 52 week low of Rs. 282.2 on 25-Aug-2015. Last one week high and low of the scrip stood at Rs. 559.4 and Rs. 524.5 respectively.

The promoters holding in the company stood at 48.3% while Institutions and Non-Institutions held 36.1% and 12.5% respectively.

Drugmakers get NPPA notice for pricing violation and other top pharma news

It is one company in the troubled largecap pharmaceuticals space, which has neither created shareholder wealth nor performed on fundamentals in the last one year.

Concerned over ‘wilful violation’ of its drug pricing control rules, the National Pharmaceutical Pricing Authority (NPPA) has slapped showcause notices on ten top drugmakers for failing to register their products on its online database and submit the mandatory disclosures. The authority, which plans to issue notices to more firms that have not furnished the information so far, warned that it would have to launch prosecution, among other legal actions, under the Essential Commodities Act. 

It is one company in the troubled largecap pharmaceuticals space, which has neither created shareholder wealth nor performed on fundamentals in the last one year. Sun Pharma is seen to be swallowing a pill far more bitter than most of its four large-cap peers — Aurobindo Pharma, Cipla, Dr Reddy’s and Lupin. This is has been revealed in an FC Research Bureau analysis of share price movement over the last one year and the fundamentals performance in financial year 2015-16 (FY16), based on data from Capitaline database. 

Drug major Lupin has committed to close the corrective action at its Goa facility, which had received nine observations from US health regulator, by December. It said that even if the US Food and Drug Administration decides to hold back appro val s from the Goa facility it won't have much impact on the company as majority of pending approvals are from its other manufacturing sites. “We have actually committed till December to the FDA, but we are trying internally to actually make it happen even sooner,” Lupin M D Nilesh Gupta said. 

Granules announced an in-licensing deal with US pharma Windlas for four abbreviated new drug applications (ANDAs) awaiting approval in the US. Granules will make milestone payments and commit share of the profits from commercial sales to US pharma Windlas. Granules expects to be a co-first-to-file (FTF) for each of products, though eventually we expect intense generic competition once other Para IV’s launch after the exclusivity period. 

Dr Reddy’s Laboratories Ltd, India’s second largest drug maker, said it plans to commercialise by 2017-18 at least four of the eight generic drugs it acquired from Israel-based Teva Pharmaceutical Industries Ltd.  Of the eight products the Indian drug maker acquired from Teva for $350 million, one has been approved by the US Food and Drug Administration (FDA) and the rest are awaiting the agency’s green light. In an email reply to questions from Mint, Hyderabad-based Dr Reddy’s said on Monday that the portfolio of acquired drugs comprised complex generic products across dosage forms and therapeutic areas with annual sales of around $3.5 billion. 

Teva Pharmaceutical says it will stop selling its migraine patch treatment Zecuity after users reported burns and scars where it was applied. The company says anyone who has a patch should not use it. Zecuity is a disposable battery-powered patch that is applied to the upper arm or thigh to ease migraine headaches. 

IVRCL allots 6.4 lakh shares to Bank of Nova Scotia; surges 5%

The Company has made an allotment of 6,46,810 equity shares at a price of Rs. 8.765/- each to Bank of Nova Scotia.

IVRCL Ltd has announced that pursuant to provisions of Companies Act, 2013 and SEBI (Issue of Capital Disclosure Requirement) Regulations, 2009 and implementation of SDR, the Company has made an allotment of 6,46,810 equity shares at a price of Rs. 8.765/- each, to Bank of Nova Scotia.

IVRCL Ltd is currently trading at Rs. 5, up 5.2% from its previous closing of Rs. 4.8 on the BSE.

The scrip opened at Rs. 4.9 and has touched a high and low of Rs. 5.1 and Rs. 4.9 respectively. The current market cap of the company is Rs. 377.8 crore.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 12.8 on 07-Aug-2015 and a 52 week low of Rs. 3.7 on 27-May-2016. Last one week high and low of the scrip stood at Rs. 4.9 and Rs. 3.8 respectively.

The promoters holding in the company stood at 5.7% while Institutions and Non-Institutions held 53.4% and 40.7% respectively.

The stock is currently trading above its 200 DMA.

Reliance Defence rises 2%

The company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

Reliance Defence stock was up by 2% at Rs. 62. Report says that the company is accelerating work on an inherited order for naval offshore patrol vessels (NOPVs) and has assured the Indian Navy of supplying all the five craft by the end of 2017.

The scrip opened at Rs. 61.9 and has touched a high and low of Rs. 63.8 and Rs. 61.8 respectively. So far 371585(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 4516.65 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 114 on 28-Dec-2015 and a 52 week low of Rs. 51.45 on 25-Aug-2015. Last one week high and low of the scrip stood at Rs. 67.75 and Rs. 58.7 respectively.

The promoters holding in the company stood at 29.9 % while Institutions and Non-Institutions held 14.22 % and 55.88 % respectively.

The stock is currently trading below its 200 DMA.

L&T plans to list L&T Infotech by October

The company had received capital markets regulator Sebi’s approval to float initial public offering worth Rs 2,000 crore in December 2015.

Larsen & Toubro is planning to list its IT arm L&T Infotech by October this year, according to reports.

Report says that the company expects to raise between Rs 2,000-2,600 crore from the initial public offer.

The company had received capital markets regulator Sebi’s approval to float initial public offering worth Rs 2,000 crore in December 2015.